INFORMATION
BOARD |

VETERINARY
NEWS
DIGEST 2000-2003
IS NOW AVAILABLE!
[ORDER
TODAY!]
|
|
|
Recent
developments in DNA technology have created new and exciting
diagnostic options in the field of avian medicine. These advancements
have made it possible to accurately detect harmful infectious
agents such as viruses, bacteria, and parasites from easy
to obtain samples such as swabs, blood or droppings. With
the increasing efficiency and availability of new diagnostic
tests, screening all newly acquired birds is highly recommended
to control the spread of pathogens, and consequently, ensure
a healthy environment for pets and pet owners alike.
Thanks to new DNA based diagnostic procedures, isolating newly
acquired birds for long periods of time prior to introducing
them to a collection is a practice long forgotten. Infectious
screening provides bird owners with the opportunity to safely
and immediately introduce new birds into their collections
without the fear of exposing them to infectious and often
deadly organisms.
Numerous harmful organisms are transmittable from animals
to humans and are occasionally responsible for causing severe
illness and disease. One such infection that is dangerous
to both humans and birds alike is tuberculosis. Tuberculosis
infection characteristically affects the respiratory system
and causes symptoms such as coughing, wheezing, trouble breathing
and other forms of general respiratory distress. DNA technology
has provided new diagnostic options that allow for accurate
detection of tuberculosis, such that early treatment may be
administered.
Avian flu is a chronic and debilitating infection caused by
an acid-fast bacterial rod known as mycobacterium. Tuberculosis
infection in birds is most commonly associated with two strains
of mycobacterium, M. avium, and M. genovense. Typically, three
histological categories of infection are observed in birds
infected by mycobacterium. The classic form is characterized
by the presence of tubercles or granulomas (walled off areas
of infection) throughout many organs in the body. Clinically,
this form affects the bird’s lungs and is associated with
respiratory distress, characteristic of tuberculosis infection.
A second observable form is associated with lesions in the
intestinal tract and is often detected in amazons, pionus,
and Brotogeris parrots. This form of infection can be particularly
hazardous since high numbers of bacteria are typically shed
in the feces creating a hostile environment ideal for disease
transmission. The third and most elusive form is known as
the nontuberculous or atypical form and is very difficult
to recognize. This form commonly occurs in finches, canaries,
and small psittacines. The liver is usually very enlarged
and large numbers of mycobacteria are commonly detected during
cytological and histopathological examination. Avian tuberculosis
is particularly deadly due to the fact that all birds are
susceptible and can potentially transmit the bacteria to humans.
High prevalence of transmission amongst birds is usually correlated
with large collections typical of zoos or high volume breeding
operations. In fact, according to some publications, tuberculosis
infection accounts for nearly 15 % of all avian deaths in
zoological parks containing mixed species. In most instances,
mycobacteria are spread by food and water contamination by
feces.
Previously, diagnosis of tuberculosis in living birds has
been extremely difficult relying on x-rays, endoscopy, and
staining for acid-fast bacteria in the feces, which is not
specific. Fortunately, contemporary advancements in DNA diagnostics
have produced new and superior techniques that enable accurate
and specific pathogenic detection. Recenty, HealthGene Laboratory
has taken diagnosis of Mycobacterium to the next level through
the introduction of a new PCR based assay that allows for
sensitive and timely detection of two strains of mycobacterium
most commonly associated with avian tuberculosis (M. genovense
and M. avium). HealthGene’s preliminary laboratory
results have shown a 3% positive infection rate from initial
samples submitted. Furthermore, in some cases, independent
government laboratories have confirmed positive results. Tuberculosis
screening is also part of HealthGene’s Health Awareness Program
aimed at promoting a pathogen-free environment for pet owners.
Test requirements are 0.1-0.3 ml of whole blood (EDTA tube)
and a fecal sample. Test code: A118 - Avian Tuberculosis.
|